Akari Therapeutics Plc: Form S-1, filed May 8, 2026
Filed with the SEC on May 8, 2026 and accepted by EDGAR at May 8, 2026, 17:08 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-26-022019. Last ingested by Listed: Nov 14, 2026, 14:34 ET. Listed shows no prices and gives no investment advice.